(Q37554819)

21 August 2017

Denosumab for management of parathyroid carcinoma-mediated hypercalcemia (English)

1 reference

21 August 2017

Priyathama Vellanki

1

1 reference

21 August 2017

Karoline Lange

2

1 reference

21 August 2017

Dina Elaraj

3

1 reference

21 August 2017

Peter A Kopp

4

1 reference

21 August 2017

Malek El Muayed

5

1 reference

21 August 2017

language of work or name

English

0 references

publication date

31 October 2013

1 reference

The Journal of Clinical Endocrinology and Metabolism

21 August 2017

1 reference

21 August 2017

99

1 reference

21 August 2017

2

1 reference

21 August 2017

387-390

1 reference

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Diagnosis and treatment of patients with parathyroid carcinoma: An update and review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Parathyroid carcinoma: clinical and pathologic features in 43 patients.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Efficacy and safety of denosumab versus zoledronic acid in patients with bone metastases: a systematic review and meta-analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Parathyroid carcinoma: update and guidelines for management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Parathyroid carcinoma: a collective review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913820

Denosumab for tumor-induced hypercalcemia complicated by renal failure

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24178790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Denosumab for the treatment of bisphosphonate-refractory hypercalcemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24178790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Parathyroid carcinoma: biochemical and pathologic response to DTIC

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24178790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1210/JC.2013-3031

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24178790

1 reference